bluebird bio Inc (BLUE)
0.4638
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.475
+0.01
(+2.41%)
After-Hours: 20:00
bluebird bio Market Cap: 89.94M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 90.36M |
| October 31, 2024 | 89.98M |
| October 30, 2024 | 94.78M |
| October 29, 2024 | 95.37M |
| October 28, 2024 | 95.91M |
| October 25, 2024 | 93.12M |
| October 24, 2024 | 96.78M |
| October 23, 2024 | 99.42M |
| October 22, 2024 | 98.06M |
| October 21, 2024 | 96.34M |
| October 18, 2024 | 95.17M |
| October 17, 2024 | 94.34M |
| October 16, 2024 | 93.43M |
| October 15, 2024 | 93.31M |
| October 14, 2024 | 97.60M |
| October 11, 2024 | 98.12M |
| October 10, 2024 | 95.93M |
| October 09, 2024 | 95.89M |
| October 08, 2024 | 94.47M |
| October 07, 2024 | 100.95M |
| October 04, 2024 | 110.53M |
| October 03, 2024 | 100.45M |
| October 02, 2024 | 94.47M |
| October 01, 2024 | 91.28M |
| September 30, 2024 | 100.74M |
| Date | Value |
|---|---|
| September 27, 2024 | 97.81M |
| September 26, 2024 | 96.47M |
| September 25, 2024 | 92.69M |
| September 24, 2024 | 96.96M |
| September 23, 2024 | 94.80M |
| September 20, 2024 | 91.18M |
| September 19, 2024 | 95.41M |
| September 18, 2024 | 95.99M |
| September 17, 2024 | 96.98M |
| September 16, 2024 | 112.02M |
| September 13, 2024 | 117.47M |
| September 12, 2024 | 111.31M |
| September 11, 2024 | 112.82M |
| September 10, 2024 | 110.61M |
| September 09, 2024 | 104.35M |
| September 06, 2024 | 102.53M |
| September 05, 2024 | 110.25M |
| September 04, 2024 | 108.62M |
| September 03, 2024 | 109.97M |
| August 30, 2024 | 108.85M |
| August 29, 2024 | 114.84M |
| August 28, 2024 | 120.83M |
| August 27, 2024 | 122.17M |
| August 26, 2024 | 135.80M |
| August 23, 2024 | 133.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
89.94M
Minimum
Nov 04 2024
2.700B
Maximum
Jan 17 2020
829.63M
Average
532.43M
Median
Market Cap Benchmarks
| Perspective Therapeutics Inc | 816.55M |
| Protalix BioTherapeutics Inc | 93.03M |
| Predictive Oncology Inc | 4.534M |
| Spectral AI Inc | 26.06M |
| Vertex Pharmaceuticals Inc | 122.14B |
Market Cap Related Metrics
| PS Ratio | 1.298 |
| PEG Ratio | -0.0016 |
| Price to Book Value | 1.698 |
| Price | 0.4638 |
| Earnings Yield | -478.7% |
| PEGY Ratio | -0.0016 |